“Bimekizumab Efficacy and Safety through Three Years in Patients With Moderate to Severe Plaque Psoriasis: Long-Term Results from the BE SURE Randomized Controlled Trial and the BE BRIGHT Open-Label Extension”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s68. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/1824.